SV2002000624A - SILDENAFIL MALEATE - Google Patents

SILDENAFIL MALEATE

Info

Publication number
SV2002000624A
SV2002000624A SV2001000624A SV2001000624A SV2002000624A SV 2002000624 A SV2002000624 A SV 2002000624A SV 2001000624 A SV2001000624 A SV 2001000624A SV 2001000624 A SV2001000624 A SV 2001000624A SV 2002000624 A SV2002000624 A SV 2002000624A
Authority
SV
El Salvador
Prior art keywords
maleate
treatment
sexual dysfunction
pharmaceutical compound
sildenafil maleate
Prior art date
Application number
SV2001000624A
Other languages
Spanish (es)
Inventor
Valle Manuel Del
Eduardo Llano
Rafael Llano
Original Assignee
Palacio John L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40091701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2002000624(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Palacio John L filed Critical Palacio John L
Priority to SV2001000624A priority Critical patent/SV2002000624A/en
Priority to PCT/EC2002/000003 priority patent/WO2003020720A1/en
Priority to MXPA04002149A priority patent/MXPA04002149A/en
Priority to KR10-2004-7003315A priority patent/KR20040071117A/en
Priority to PA20028553601A priority patent/PA8553601A1/en
Priority to UY27426A priority patent/UY27426A1/en
Priority to GT200200177A priority patent/GT200200177A/en
Priority to ARP020103342A priority patent/AR037811A1/en
Publication of SV2002000624A publication Critical patent/SV2002000624A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere tanto a un compuesto farmacéutico para el tratamiento de la disfunción sexual masculina como a el procedimiento para su preparación. La invención consiste en un compuesto farmacéutico 5-[2-etoxi-5-(4-metilpiperazina-1-isulfonil) penil]-1-metil-3-n-propil-1,6-dihidro-7H-pirazolo[4,3-d]pirimida-7ona MALEATE, que se utiliza en el tratamiento de la disfunción sexual, asi como procedimiento de elaboración.The present invention relates both to a pharmaceutical compound for the treatment of male sexual dysfunction and to the process for its preparation. The invention consists of a pharmaceutical compound 5- [2-ethoxy-5- (4-methylpiperazine-1-isulfonyl) penyl] -1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo [4, 3-d] pyrimide-7ona MALEATE, which is used in the treatment of sexual dysfunction, as well as elaboration procedure.

SV2001000624A 2001-09-05 2001-09-05 SILDENAFIL MALEATE SV2002000624A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SV2001000624A SV2002000624A (en) 2001-09-05 2001-09-05 SILDENAFIL MALEATE
PCT/EC2002/000003 WO2003020720A1 (en) 2001-09-05 2002-07-16 Sildenafil maleate
MXPA04002149A MXPA04002149A (en) 2001-09-05 2002-07-16 Sildenafil maleate.
KR10-2004-7003315A KR20040071117A (en) 2001-09-05 2002-07-16 Sildenafil maleate
PA20028553601A PA8553601A1 (en) 2001-09-05 2002-08-22 SILDENAFIL MALEATE
UY27426A UY27426A1 (en) 2001-09-05 2002-08-29 SILDENAFIL MALEATE
GT200200177A GT200200177A (en) 2001-09-05 2002-09-03 SILDENAFIL MALEATE
ARP020103342A AR037811A1 (en) 2001-09-05 2002-09-04 SILDENAFIL MALEATE FOR THE TREATMENT OF MALE SEXUAL DYSFUNCTION, PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITION THAT INCLUDES IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SV2001000624A SV2002000624A (en) 2001-09-05 2001-09-05 SILDENAFIL MALEATE

Publications (1)

Publication Number Publication Date
SV2002000624A true SV2002000624A (en) 2002-09-12

Family

ID=40091701

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000624A SV2002000624A (en) 2001-09-05 2001-09-05 SILDENAFIL MALEATE

Country Status (8)

Country Link
KR (1) KR20040071117A (en)
AR (1) AR037811A1 (en)
GT (1) GT200200177A (en)
MX (1) MXPA04002149A (en)
PA (1) PA8553601A1 (en)
SV (1) SV2002000624A (en)
UY (1) UY27426A1 (en)
WO (1) WO2003020720A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017016930A (en) * 2017-12-19 2019-06-20 Malesil Research & Tech Llc Method of treatment of diabetic foot ulcers.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000199A1 (en) * 1998-06-26 2000-01-06 Nastech Pharmaceutical Company, Inc. Nasal delivery of sildenafil citrate
IL130968A (en) * 1999-07-15 2002-12-01 Shmuel Simon Pharmaceutical composition comprising sildenafil or its analogs, useful for the treatment of tinnitus and hearing loss
AU1888800A (en) * 1999-09-13 2001-04-17 Cipla Limited A novel process for the synthesis of sildenafil citrate

Also Published As

Publication number Publication date
UY27426A1 (en) 2003-04-30
AR037811A1 (en) 2004-12-09
GT200200177A (en) 2003-06-05
PA8553601A1 (en) 2003-05-14
WO2003020720A1 (en) 2003-03-13
MXPA04002149A (en) 2005-03-07
KR20040071117A (en) 2004-08-11

Similar Documents

Publication Publication Date Title
WO1999066063A3 (en) Nucleosidic and non-nucleosidic folate conjugates
HRP20050712A2 (en) SUBSTITUTED HEXAHYDROPYRAZINO[1,2-a]PYRIMIDIN-4,7-DION DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS
ATE403657T1 (en) CHEMICAL COMPOUNDS
TW200745121A (en) Chemical compound
BR0014698A (en) Pyrazolo [4,3-d] pyrimidine derivatives
PA8462401A1 (en) DERIVATIVES OF THENOPyrimidine AND THENOPyridine USEFUL AS ANTI-CANCER AGENTS
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
CR8117A (en) PHOSPHORIC ACID SALT OF A DIPEPTIDIL PEPTIDASA-IV INHIBITOR
HN1999000080A (en) ISOTIAZOL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS.
NO2010020I2 (en)
TW200745127A (en) Pyrazolopyrimidines as protein kinase inhibitors
DE69922823D1 (en) 6-SUBSTITUTED PYRAZOLO (3,4-d) PYRIMIDIN-4-ONE USES AS CYCLIN-DEPENDENT KINASE-INHIBITORS
MY137843A (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
MY148652A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
GEP20094720B (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
BR0316753A (en) Treatment method for sexual dysfunction
CY1111252T1 (en) MEDICAL COMPOSITIONS FOR INTRODUCTION OF CYSTEOUS CANCER CANCER
WO2004096233A3 (en) Nucleoside phosphonate conjugates
BR0109598A (en) Tricyclic protein kinase inhibitors
ATE264861T1 (en) 5-HETEROCYCLYL-PYRAZOLO(4,3-D)PYRIMIDINE-7-ONE FOR THE TREATMENT OF MALE ERECTILE DYSFUNCTION
WO2005044818A3 (en) Imidazo[1,2-a]pyridine anxiolytics
EP1634883A4 (en) 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole¬2,3-d pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
MXPA04000779A (en) Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of disease.
TR200402588T3 (en) Process of production of N- [3- (3-cyanopyrazolo [1,5-A] pyrimidin-7-yl) phenyl] -N-ethylacetamide (zaleplone)
SV2002000624A (en) SILDENAFIL MALEATE

Legal Events

Date Code Title Description
FG Grant